Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis-Reference-Cited by-同舟云学术

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

Published:2019-08-10 Issue:5 Volume:32 Page:811-821
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Brandenburg Vincent M.,Sinha Smeeta,Torregrosa Jose-Vicente,Garg Rekha,Miller Stephan,Canals Ana-Zeralda,Bahr Daun,Joubert Pieter H.,Salcedo Carolina,Carroll Kevin J.,Gold Alex,Perelló Joan

Funder

Laboratoris Sanifit

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-019-00631-0.pdf

Reference33 articles.

1. Goel SK, Bellovich K, McCullough PA (2011) Treatment of severe metastatic calcification and calciphylaxis in dialysis patients. Int J Nephrol 2011:701603. https://doi.org/10.4061/2011/701603

2. Nunley JR (2017) Calciphylaxis. https://emedicine.medscape.com/article/1095481-overview . Accessed 1 June 2019

3. Schlieper G, Brandenburg V, Ketteler M, Floege J (2009) Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5:539–543. https://doi.org/10.1038/nrneph.2009.99

4. Oliveira TM, Frazao JM (2015) Calciphylaxis: from the disease to the diseased. J Nephrol 28:531–540. https://doi.org/10.1007/s40620-015-0192-2

5. Angelis M, Wong LL, Myers SA, Wong LM (1997) Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 122:1083–1089. https://doi.org/10.1016/S0039-6060(97)90212-9 (discussion 1089–1090)

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension;eClinicalMedicine;2024-09

2. New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease;Current Opinion in Nephrology & Hypertension;2024-04-04

3. SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis;Journal of Nephrology;2024-03-21

4. Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification;Frontiers in Pharmacology;2024-02-07

5. Penile and digital calciphylaxis: A case report and literature review;Clinical Nephrology;2023-08-01